Skip to content

Meditation-Based Stress Reduction in Rheumatoid Arthritis

Mindfulness Meditation-Based Stress Reduction in Relieving Symptoms Associated With Rheumatoid Arthritis

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00071292
Enrollment
80
Registered
2003-10-21
Start date
2003-07-31
Completion date
2005-03-31
Last updated
2008-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Keywords

rheumatoid arthritis, stress reduction, meditation, mindfulness, MBSR, mindfulness-based stress reduction, mind-body skills

Brief summary

The purpose of this study is to determine whether a mindfulness meditation-based stress reduction program is useful in relieving symptoms associated with rheumatoid arthritis (RA).

Interventions

BEHAVIORALstress reduction program
BEHAVIORALmeditation

Sponsors

National Center for Complementary and Integrative Health (NCCIH)
Lead SponsorNIH

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Confirmed diagnosis of RA, with doctor's letter or doctors' bill with ICD code 714; * 18 years of age or older; * Able to read and write English; * Able to attend 15 course sessions and questionnaire sessions at Kernan Hospital in Baltimore; * Willing to practice skills for 45 minutes to 1 hour per day, 6 days a week; * Stable on rheumatoid medications for at least one month.

Exclusion criteria

* Major psychiatric illness (bipolar disorder, multiple personality disorder, etc.); * Active alcoholism or drug dependency; * Scheduled for major surgery during the study period; * Enrolled in randomized clinical trial for rheumatoid arthritis during the study period; * Planning to move out of the area in the next 12 months; * Unwilling to be enrolled in a control group; * Use of assistive device other than a cane; * Serious health condition(s) that the investigator determines would make it difficult to complete the 6 month study; * Diagnosis of fibromyalgia.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026